NCT01982097
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Multiple Locations, Russia
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,040 public trials
1,178 recruiting studies
Adenocarcinoma trial results
NCT01963325
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Completed
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
NCT01460134
- Conditions
- Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
- Locations
-
- Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
- Stanford Cancer Center - Stanford University Stanford, California, United States
- Mayo Clinic Rochester, Minnesota, United States
- Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
- Locations
-
- East Bay Radiation Oncology Center Castro Valley, California, United States
- Valley Medical Oncology Consultants - Castro Valley Castro Valley, California, United States
- Valley Medical Oncology Fremont, California, United States
- Contra Costa Regional Medical Center Martinez, California, United States
NCT00782275
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt Univeristy Medical Center Nashville, Tennessee, United States
NCT02806648
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +16 more
- Locations
-
- ICO L'Hospitalet de Llobregat, Barcelona, Spain
- C. H. de Navarra Pamplona, Navarre, Spain
- H.U.C de Asturias Oviedo, Principality of Asturias, Spain
- H. Vall d´Hebron Barcelona, Spain
NCT02400788
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Chiba, Japan
- Ishikawa, Japan
- Kanagawa, Japan
- Kochi, Japan
NCT01011010
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
- Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
Completed
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
NCT01043172
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- National Cancer Center Goyang-si, Gyeonggi-do, South Korea
NCT02202317
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Jackson Health System Miami, Florida, United States